Lack of the antimutagenic effect of ascorbic acid on the genotoxicity of albendazole in mouse bone marrow cells

• Autorzy: Alkan F.U. , Sener S.
• Języki publikacji: EN

Abstrakty

EN

The present study was designed to evaluate the genotoxicity of albendazole (ABZ) in mice using the micronucleus test. Mice were treated by gavage with 500, 1,000, and 1,500 mg of ABZ kg⁻¹ b.w., which corresponds to 1/6, 1/3, and 1/2 of the oral LD₅₀ of ABZ. In the second part of the study, the possible protective role of vitamin C (vit. C) was investigated against the genotoxic effect of ABZ. The mice received 200 mg of vit C kg⁻¹ b.w. simutaneously with ABZ. Bone marrow samples were taken 48 h after the treatment. ABZ induced a statistically significant increase (P<0.001) in the percentage of micronucleaoted polychromatic erythrocytes (MNPCE) in the 1,000 and 1,500 mg of ABZ kg⁻¹ b.w. treatment groups when compared with the negative control. On the other hand, the percentage of induced MNPCE was reduced at various levels in all ABZ treated groups simultaneously treated with an oral administration of vit. C. There were no statistically significant differences in the MNPCE frequency of these groups. The results of the study indicated that ABZ is a potential genotoxic agent, and that no protective effects of vit. C were observed against the genotoxicity of ABZ.

• Wydawca: -
• Czasopismo: Bulletin of the Veterinary Institute in Puławy
• Rocznik: 2009
• Tom: 53
• Numer: 3
• Opis fizyczny: p.493-497,ref.

Twórcy

autor

Alkan F.U.

• Department of Pharmacology and Toxicology, Faculty of Veterinary Medicine, Istanbul University, Avcilar, 34320, Istanbul, Turkey

autor

Sener S.

• Department of Pharmacology and Toxicology, Faculty of Veterinary Medicine, Istanbul University, Avcilar, 34320, Istanbul, Turkey

Bibliografia

• 1. Aardema M. J., Kirsch-Volders M.: The in vitro micronucleus assay. In: Genetic Toxicology and Cancer Risk Assessment, edited by W.N Choy, Informa Healthcare, New York, 2001, pp. 163-186.
• 2. Aly F.A.E., Donya S.M.: In vivo antimutagenic effect of vitamins C and E against rifampicin-induced chromosome aberrations in mouse bone-marrow cells. Mutat Res 2002, 518, 1-7.
• 3. Antunes L.M.G., Araújo M.C.P., Darin J.D.C., Bianchi M.L.P.: Effects of the antioxidants curcumin and vitamin C on cisplatin-induced clastogenesis in Wistar rat bone marrow cells. Mutat Res 2000, 465, 131-137.
• 4. Antunes L.M.G., Takahashi C.S.: Effects of high doses of vitamins C and E against doxorubicin-induced chromosomal damage in Wistar rat bone marrow cells. Mutat Res 1998, 419, 137-143.
• 5. Campbell W.C.: Benzimidazoles: Veterinary Uses. Parasitol Today 1990, 6, 130-133.
• 6. European Medicines Agency (EMEA): Committee for veterinary medicinal products, Albendazole - Summary Report, London, 2004.
• 7. Fenech M.:The in vitro micronucleus technique. Mutat Res 2000, 455, 81-95.
• 8. Fenech M., Morley A.A.: Measurement of micronuclei in lymphocytes. Mutat Res 1985, 147, 29-36.
• 9. Franke S.I.R., Prá D., Silva J., Erdtmann B., Henriques J.A.P.: Possible repair action of vitamin C on DNA damage induced by methyl methanesulfonate, cyclophosphamide, FeSO₄ and CuSO₄ in mouse blood cells in vivo. Mutat Res 2005, 583, 75-84.
• 10. Gentile J.M., Rahimi S., Zwiesler J., Gentile G.J., Ferguson L.R.: Effect of selected antimutagens on the genotoxicity of antitumour agents. Mutat Res 1998, 402, 289-298.
• 11. Giri A., Khynriam D., Prasad S.B.: Vitamin C mediated protection on cisplatin induced mutagenicity in mice. Mutat Res 1998, 421, 139-148.
• 12. Guha B., Das J.K., Khuda-Bukhsh A.R.: Ameliorative effects of vitamin supplementation on ethyl methane sulphonate-induced genotoxicity in a fish, Anabas testudineus. Ecotox Environ Safe 2007, 68, 63-70.
• 13. Halliwell B.: Vitamin C and genomic stability. Mutat Res 2001, 475, 29-35.
• 14. Hayashi M., Tice R.R., MacGregor J.T., Anderson D., Blakey D.H., Kirsh-Volders M., Oleson F.B., Pacchierotti F., Romagna F., Shimada H., Sutou S., Vannier B.: In vivo rodent erythrocyte micronucleus assay. Mutat Res 1994, 312, 293-304.
• 15. Joint FAO/WHO Expert Committee on Food Additives (JECFA): Toxicological evaluation of certain veterinary drug residues in food, albendazole. WHO Food Additive Series, 1990, 25, 3-29.
• 16. Kaya B.: Anti-genotoxic effect of ascorbic acid on mutagenic dose of three alkylating agents. Turk J Biol 2003, 27, 241-246.
• 17. Konopacka M., Widel M., Rzeszowska-Wolny J.: Modifying effect of vitamins C, E, and β-carotene against β-ray-induced DNA damage in mouse cells. Mutat Res 1998, 417, 85-94.
• 18. Krishna G., Nath J., Ong T.: Inhibition of cyclophosphamide and mitomycin-C induced sister chromatid exchanges in mice by vitamin-C. Cancer Res 1986, 46, 2670-2674.
• 19. Krishnaja A.P., Sharma N.K.: Ascorbic acid potentiates mitomycin C-induced micronuclei and sister chromatid exchanges in human peripheral blood lymphocytes in vitro. Teratogen Carcin Mut 2003, 23, 99-112.
• 20. Lacey E.: Mode of action of benzimidazoles. Parasitol Today 1990, 6, 112-115.
• 21. Lialiaris T., Mourelatos D., Dozi-Vassiliades J.: Enhancement and attenuation of cytogenetic damage by vitamin C in cultured human lymphocytes exposed to Thiotepa or L-ethionine. Cytogenet Cell Genet 1987, 44, 209-214.
• 22. McKellar Q.A., Jackson F.: Veterinary anthelmintics: old and new. Trends Parasitol 2004, 20, 456-461.
• 23. McKellar Q.A., Scott E.W.: The benzimidazole anthelmintic agents - a review. J Vet Pharmacol Ther 1990, 13, 223-247.
• 24. Nare B., Liu Z., Prichard R.K., Georges E.: Benzimidazoles, potent anti-mitotic drugs: Substrates for the P-glycoprotein transporter in multidrug-resistant cells. Biochem Pharmacol 1994, 48, 2215-2222.
• 25. Navarrete-Vázquez G., Yépez L., Hernández-Campos A., Tapia A., Hernández-Luis F., Cedillo R., González J., Martínez-Fernández A., Martínez-Grueiro M., Castillo R.: Synthesis and antiparasitic activity of albendazole and mebendazole analogues. Bioorgan Med Chem 2003, 11, 4615-4622.
• 26. Nefic H.: Anticlastogenic effect of vitamin C on cisplatin induced chromosome aberrations in human lymphocyte cultures. Mutat Res 2001, 498, 89-98.
• 27. Norkus E.P., Kuenzig W., Conney A.H.: Studies on the mutagenic activity of ascorbic acid in vitro and in vivo. Mutat Res 1983, 117, 183-191.
• 28. Odin A.P.: Vitamins as antimutagens: Advantages and some possible mechanisms of antimutagenic action. Mutat Res 1997, 386, 39-67.
• 29. Organisation for Economic Co-operation and Development (OECD). Guideline for Testing of Chemicals 474. Mammalian Erythrocyte Micronucleus Test. Paris, 1997.
• 30. Oztas S., Salman A.B., Tatar A., Yigiter M., Yazgi H., Ertek M., Yesilyurt A., Ocak Z., Kursad H.: Genotoxic effect of albendazole in pediatric patients with hepatic hydatid disease. Int J Infect Dis 2007, 11, 446-449.
• 31. Ramírez T., Benítez-Bribiesca L., Ostrosky-Wegman P., Herrera L.A.: In vitro effects of albendazole and its metabolites on the cell proliferation kinetics and micronuclei frequency of stimulated human lymphocytes. Arch Med Res 2001, 32, 119-122.
• 32. Ramírez T., Eastmond D.A., Herrera L.A.: Nondisjunction events induced by albendazole in human cells. Mutat Res 2007, 626, 191-195.
• 33. Rosin M.P., San R.H.C., Stich H.F.: Mutagenic activity of ascorbate in mammalian cell cultures. Cancer Lett 1980, 8, 299-305.
• 34. Salamone M.F., Heddle J.A., Stuart E., Katz M.: Towards an improved micronucleus test. Studies on 3 model agents: mitomycin C, cyclophosphamide, and dimethylbenzanthracene. Mutat Res 1980, 74, 347-356.
• 35. Schmid W.: The micronucleus test. Mutat Res 1975, 31, 9-15.
• 36. Seiler J.P.: Toxicology and genetic effects of benzimidazole compounds. Mutat Res 1975, 32, 151- 167.
• 37. Singh M., Kaur P., Sandhir R., Kiran R.: Protective effects of vitamin E against atrazine-induced genotoxicity in rats. Mutat Res 2008, 654, 145-149.
• 38. Šiviková K., Piešová E., Dianovsk J.: The protection of vitamin E and selenium against carbon tetrachloride-induced genotoxicity in ovine peripheral blood lymphocytes. Mutat Res 2001, 494, 135-142.
• 39. Vijayalaxmi K.K., Venu R.: In vivo anticlastogenic effects of L-ascorbic acid in mice. Mutat Res 1999, 438, 47-51.